A cancer researcher specializing in experimental oncology and virology, likely with a strong background in molecular biology and genetics.
Despite the demands of the holiday season, the significance of maintaining momentum in our preclinical studies on oncolytic virotherapy cannot be overstated; continued progress is imperative for advancing our understanding of this promising therapeutic modality.